| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |